Clinical trials
Completed Lung Diseases, Interstitial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 8 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 7 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 80 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 9 |
| Duke University | 4 |
| Columbia University | 3 |
| Johns Hopkins University | 3 |
| United Therapeutics | 3 |
| Weill Medical College of Cornell University | 3 |
| Lung Institute | 2 |
| Mayo Clinic | 2 |
| Michael Roth | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 80 |
| Idiopathic Pulmonary Fibrosis | 21 |
| Pulmonary Fibrosis | 15 |
| Pulmonary Disease, Chronic Obstructive | 12 |
| Hypertension, Pulmonary | 9 |
| Dyspnea | 7 |
| Heart Failure | 7 |
| Pulmonary Arterial Hypertension | 7 |
| Sarcoidosis | 5 |
| Scleroderma, Systemic | 5 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.